Literature DB >> 17360857

Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay.

Magdia De Jesus1, Emily Hackett, Michelle Durkin, Patricia Connolly, Arturo Casadevall, Ruta Petraitiene, Thomas J Walsh, L Joseph Wheat.   

Abstract

Given the recent report of a false-positive result in the Platelia Aspergillus enzyme immunoassay in a patient with cryptococcosis and in yeast extracts and purified galactoxylomannan of Cryptococcus neoformans, we evaluated culture extracts, purified polysaccharides, clinical specimens, and specimens from animals following experimental infection. Our results revealed no cross-reactions.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17360857      PMCID： PMC1865626          DOI： 10.1128/CVI.00368-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  13 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.

Authors:  C M Swanink; J F Meis; A J Rijs; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.

Authors:  W Chaka; A F Verheul; V V Vaishnav; R Cherniak; J Scharringa; J Verhoef; H Snippe; A I Hoepelman
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

4.  Detection of circulating galactomannan by Pastorex Aspergillus in experimental invasive aspergillosis.

Authors:  J Van Cutsem; L Meulemans; F Van Gerven; D Stynen
Journal:  Mycoses       Date:  1990-02       Impact factor: 4.377

5.  The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction.

Authors:  Diane C McFadden; Magdia De Jesus; Arturo Casadevall
Journal:  J Biol Chem       Date:  2005-11-08       Impact factor: 5.157

6.  Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan.

Authors:  Frédéric Dalle; Pierre Emmanuel Charles; Karine Blanc; Denis Caillot; Pascal Chavanet; Françoise Dromer; Alain Bonnin
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans.

Authors:  S H Turner; R Cherniak; E Reiss
Journal:  Carbohydr Res       Date:  1984-02-15       Impact factor: 2.104

Review 8.  Galactomannan antigen detection in the diagnosis of invasive aspergillosis.

Authors:  Virginia Verdaguer; Thomas J Walsh; William Hope; Karoll J Cortez
Journal:  Expert Rev Mol Diagn       Date:  2007-01       Impact factor: 5.225

9.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Rat monoclonal antibodies against Aspergillus galactomannan.

Authors:  D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441
View more
  12 in total

1.  Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay.

Authors:  Melissa O Xavier; Alessandro C Pasqualotto; Isabel Cristina E Cardoso; Luiz Carlos Severo
Journal:  Clin Vaccine Immunol       Date:  2008-11-19

2.  Nonculture diagnostic methods for invasive fungal infections.

Authors:  L Joseph Wheat
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

3.  Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.

Authors:  Magdia De Jesus; André Moraes Nicola; Marcio L Rodrigues; Guilhem Janbon; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2008-10-24

4.  Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay.

Authors:  David Zhuang; Chadi Hage; Magdia De Jesus; Emily Hackett; Michelle Durkin; Thomas E Davis; Arturo Casadevall; L Joseph Wheat
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

5.  Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus.

Authors:  Yu-Tsung Huang; Chien-Ching Hung; Chun-Hsing Liao; Hsin-Yun Sun; Shan-Chwen Chang; Yee-Chun Chen
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

6.  Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.

Authors:  Magdia De Jesus; Siu-Kei Chow; Radames J B Cordero; Susana Frases; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2010-01-08

7.  Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.

Authors:  Takahiro Takazono; Tomomi Saijo; Nobuyuki Ashizawa; Kazuhiro Oshima; Keitaro Nishimura; Masato Tashiro; Kazuko Yamamoto; Yoshifumi Imamura; Taiga Miyazaki; Katsunori Yanagihara; Hiroshi Mukae; Koichi Izumikawa; Donald C Sheppard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-25       Impact factor: 3.267

8.  Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis.

Authors:  Christopher R Thornton
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

Review 9.  Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay.

Authors:  L J Wheat; T J Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

10.  Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1.

Authors:  Magdia De Jesus; Chae Gyu Park; Ya Su; David L Goldman; Ralph M Steinman; Arturo Casadevall
Journal:  Med Mycol       Date:  2008-03       Impact factor: 4.076
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.